Literature DB >> 28348469

The Preliminary Study on Procurement Biliary Convergence from Donors with Complicated Bile Duct Variant in Emergency Right Lobe Living Donor Liver Transplantation.

Sheng Ye1, Jia-Hong Dong1, Wei-Dong Duan2, Wen-Bing Ji2, Yu-Rong Liang2.   

Abstract

BACKGROUND: The incidence of biliary complications after living donor adult liver transplantation (LDALT) is still high due to the bile duct variation and necessity reconstruction of multiple small bile ducts. The current surgical management of the biliary variants is unsatisfactory. We evaluated the role of a new surgical approach in a complicated hilar bile duct variant (Nakamura type IV and Nakamura type II) under emergent right lobe LDALT for high model for end-stage liver disease score patients.
METHODS: The common hepatic duct (CHD) and the left hepatic duct (LHD) of the donor were transected in a right-graft including short common trunks with right posterior and anterior bile ducts, whereas the LHD of the donor was anastomosed to the CHD and the common trunks of a right-graft bile duct and the recipient CHD was end-to-end anastomosed.
RESULTS: Ten of 13 grafts (Nakamura types II, III, and IV) had two or more biliary orifices after right graft lobectomy; seven patients had biliary complications (53.8%). Later, the surgical innovation was carried out in five donors with variant bile duct (four Nakamura type IV and one type II), and, consequently, no biliary or other complications were observed in donors and recipients during 47-53 months of follow-up; significant differences (P < 0.05) were found when two stages were compared.
CONCLUSION: Our initial experience suggests that, in the urgent condition of LDALT when an alternative live donor was unavailable, a surgical innovation of cutting part of the CHD trunks including variant right hepatic ducts in a complicated donor bile duct variant may facilitate biliary reconstruction and reduce long-term biliary complications.

Entities:  

Keywords:  CHD, common hepatic duct; CUSA, cavitron ultrasonic surgical aspirator; CVP, central venous pressure; HTK, histidine-tryptophan-ketoglutarate; LDALT, living donor adult liver transplantation; LDLT; LHD, left hepatic duct; MELD, model for end-stage liver disease; MHA, middle hepatic artery; MHV, middle hepatic vein; MRCP, magnetic resonance cholangiopancreatography; PHA, proper hepatic artery; RHA, right hepatic artery; RHD, right hepatic duct; RHV, right hepatic vein; RPV, right portal vein; bile duct variant; biliary complications; surgical innovation

Year:  2016        PMID: 28348469      PMCID: PMC5357717          DOI: 10.1016/j.jceh.2016.09.016

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  17 in total

1.  Liver anatomy: portal (and suprahepatic) or biliary segmentation.

Authors:  C Couinaud
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  Anatomical variations and surgical strategies in right lobe living donor liver transplantation: lessons from 120 cases.

Authors:  Taro Nakamura; Koichi Tanaka; Tetsuya Kiuchi; Mureo Kasahara; Fumitaka Oike; Mikiko Ueda; Satoshi Kaihara; Hiroto Egawa; Ilgin Ozden; Nobuaki Kobayashi; Shinji Uemoto
Journal:  Transplantation       Date:  2002-06-27       Impact factor: 4.939

3.  Biliary reconstruction using the cystic duct in right lobe living donor liver transplantation.

Authors:  Kyung-Suk Suh; Seok Ho Choi; Nam-Joon Yi; Choon Hyuck Kwon; Kuhn Uk Lee
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

4.  Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft.

Authors:  S T Fan; C M Lo; C L Liu
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

5.  Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery.

Authors:  Takayuki Tohma; Akihiro Cho; Shinichi Okazumi; Harufumi Makino; Kiyohiko Shuto; Ryoyu Mochiduki; Katsuhiko Matsubara; Hisashi Gunji; Takenori Ochiai
Journal:  Radiology       Date:  2005-08-18       Impact factor: 11.105

6.  "All-in-one" imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography.

Authors:  Tobias Schroeder; Massimo Malagó; Jörg F Debatin; Mathias Goyen; Silvio Nadalin; Stefan G Ruehm
Journal:  Liver Transpl       Date:  2005-07       Impact factor: 5.799

Review 7.  Biliary complications after a right-lobe living donor liver transplantation.

Authors:  Shujiro Yazumi; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

8.  Feasibility of using the cystic duct for biliary reconstruction in right-lobe living donor liver transplantation.

Authors:  Katsuhiro Asonuma; Hideaki Okajima; Mikako Ueno; Takayuki Takeichi; Manuel E Zeledon Ramirez; Yukihiro Inomata
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

9.  Duct-to-duct biliary reconstruction in living donor liver transplantation utilizing right lobe graft.

Authors:  Takatoshi Ishiko; Hiroto Egawa; Mureo Kasahara; Taro Nakamura; Fumitaka Oike; Satoshi Kaihara; Tetsuya Kiuchi; Shinji Uemoto; Yukihiro Inomata; Koichi Tanaka
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  The utility of MRCP in preoperative mapping of biliary anatomy in adult-to-adult living related liver transplant donors.

Authors:  Piyaporn Limanond; Steven S Raman; R Mark Ghobrial; Ronald W Busuttil; David S K Lu
Journal:  J Magn Reson Imaging       Date:  2004-02       Impact factor: 4.813

View more
  2 in total

Review 1.  CT and MR imaging evaluation of living liver donors.

Authors:  Federica Vernuccio; Susan A Whitney; Kadiyala Ravindra; Daniele Marin
Journal:  Abdom Radiol (NY)       Date:  2021-01

2.  Remote-controlled cholangiography injection device: first clinical study in China.

Authors:  Huan Chen; Li-Yu Shan; Tao Ma; Yue Wang; Zhe Feng; Ding-Hui Dong; Yi Lv; Hao-Yang Zhu
Journal:  BMC Gastroenterol       Date:  2022-01-07       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.